newsfilter
← Earnings
Earnings Releases·

Profound Medical — Third Quarter 2026 Earnings Summary

Profound Medical reported third-quarter 2026 revenue of $9.8 million, an 86% increase year-over-year, driven by $5.7 million in capital equipment sales and $4.1 million in recurring revenue. The company achieved a gross margin of 78% and reduced cash used in operating activities by 56% sequentially to $5.0 million. Profound announced a new distribution agreement with Cook Medical to expand U.S. sales of its TULSA-PRO system and projected full-year 2026 revenue to reach at least $25.0 million. Leadership changes include the appointment of Richard Fabian as CEO effective January 14, 2027, with Arun Menawat transitioning to Executive Chairman.

Company
PROFOUND MEDICAL CORP
Sector
Healthcare
Industry
Medical Devices